In HCC cancer cells, the ectopic expression of αB-Crystallin promotes resistance to sorafenib by inducing EMT and subsequently activating the ERK1/2/FOSL1/slug signaling pathway [117]. The gene discussed is FOSL1; the disease is cancer.